Navigation Links
Optimer Pharmaceuticals Obtains Additional Fidaxomicin Patent
Date:1/5/2011

SAN DIEGO, Jan. 5, 2011 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) announced today that the United States Patent and Trademark Office has issued U.S. Patent 7,863,249 which covers additional dosage forms of fidaxomicin. This patent further strengthens Optimer's patent protection for fidaxomicin. The newly issued patent and a previously issued patent encompassing fidaxomicin are both orange book listable.

(Logo: http://photos.prnewswire.com/prnh/20090413/LA97352LOGO)

"The issuance of this patent is part of our intellectual property strategy to protect fidaxomicin in all methods and dosages for treating patients with Clostridium difficile infection," said Pedro Lichtinger, President and CEO of Optimer.  

Fidaxomicin is a narrow spectrum antibiotic being developed for the treatment of Clostridium difficile infection (CDI). In two Phase 3 trials for the treatment of CDI, fidaxomicin was equally effective in clinical cure when compared to vancomycin, the only FDA approved product for CDI.  Most importantly, fidaxomicin was statistically superior to vancomycin in global cure and in reducing recurrences of CDI by up to 47%. Optimer has filed marketing applications in the U.S. and the EU for fidaxomicin for the treatment of CDI and for the prevention of recurrences.

About Optimer PharmaceuticalsOptimer Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing hospital specialty products to treat serious infections and address unmet medical needs. Optimer has two anti-infective product candidates in development, fidaxomicin and Pruvel™ (prulifloxacin).  Fidaxomicin is a narrow spectrum antibiotic being developed for the treatment of Clostridium difficile infection (CDI).  The Co
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Optimer Pharmaceuticals Receives Production Patent for Lead Product Candidate Fidaxomicin
2. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
3. Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
4. Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection (CDI)
5. Optimer Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
6. Optimer Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
7. Optimer Pharmaceuticals Fidaxomicin Marketing Authorization Application Accepted for Review by European Medicines Agency
8. Optimer Pharmaceuticals to Present at September 2010 Investor Conferences
9. Optimer Pharmaceuticals Announces Presentations of Additional Fidaxomicin Phase 3 Data at Upcoming ICAAC Annual Meeting
10. Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA
11. Optimer Pharmaceuticals to Host Investor and Analyst Event on November 18
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013  CAS Medical Systems, Inc. (NASDAQ: CASM ... monitoring, today announced that Thomas M. Patton ... 2 nd Annual Marcum MicroCap Conference on Thursday, May ... New York City . The presentation is ... 10 room and will be available via a live webcast ...
(Date:5/23/2013)... , May 23, 2013  Intercept Pharmaceuticals, Inc. ... biopharmaceutical company focused on the development and commercialization of ... such as primary biliary cirrhosis, today announced that ... Executive Officer, will present at the Deutsche Bank Securities ... on Wednesday, May 29, 2013 at 4:10 ...
(Date:5/23/2013)... , May 23, 2013 Isis Pharmaceuticals, Inc. ... today announced that management will present a company overview at ... Conference on Thursday, May 30, 2013 at 8:40 a.m. ET ... live audio webcast of the presentation will be available on ... www.isispharm.com .  A replay will be available on the ...
Breaking Medicine Technology:CASMED to Present at the 2nd Annual Marcum MicroCap Conference 2Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference 2
... Cochlear Americas, the global leader in implantable hearing solutions, ... Clark Scholarship awards. Five students have been selected to ... a degree at an accredited university, for a total ... and pioneer of the cochlear implant, the program was ...
... Reportlinker.com announces that a new market research report ... U.S. Pain Management Products & Services: A Market ... http://www.reportlinker.com/p0396125/US-Pain-Management-Products--Services-A-Market-Analysis---7th-edition.html This has grown into ... in turmoil. More than 9,000 programs and sole ...
Cached Medicine Technology:Cochlear Americas Announces 2011 Graeme Clark Scholarship Winners 2Cochlear Americas Announces 2011 Graeme Clark Scholarship Winners 3Reportlinker Adds U.S. Pain Management Products & Services: a Market Analysis - 7th Edition 2
(Date:5/23/2013)... carries a poor prognosis, with limited treatment options. ... the way it,s supposed to. New research from Western ... chemotherapy, and identifies a mechanism to rectify that. ... and his team at Western,s Schulich School of Medicine ... to promote the death of cancer cells by binding ...
(Date:5/23/2013)... May 23, 2013 Former United States ... for Acadian 's annual Paramedic Luncheon. , ... Convention Center, Cheney praised Acadian's medics, saying, "I am ... participate in awarding the Paramedic of the Year Award. ... is a lot of competition within a company like ...
(Date:5/23/2013)... On April 29th, 2013, UV Technologies issued ... H7N9 cases and deaths. The headline read, " UV Technologies, ... in Northern Hemisphere as Available Daylight Increases .” In fact, ... , Quoting Kevin McGuire, president of UV Technologies, "The ... in the spring and leaves changing in the fall. The ...
(Date:5/23/2013)... 2013 EnvirOasis, the leader in energy ... market is pleased to announce its new line of ... products. EnvirOasis has been a market leader in ... kits and has recently brought to market a full ... Diode) is energy efficient lighting technology which produces a ...
(Date:5/23/2013)... HealthDay Reporter , , THURSDAY, May 23 (HealthDay News) -- ... especially among Hispanic teens, according to a new government report. ... to 19 dropped by nearly one half from 1991 to ... to 31 births for every 1,000. From 2007 to ... percent, from 41.5 to about 31. During that time, ...
Breaking Medicine News(10 mins):Health News:Acadian Ambulance Honors Paramedic of the Year at Annual Luncheon 2Health News:UV Technologies Bold Prediction on H7N9 in China Comes True, New Cases End Without Aid of Flu Vaccine 2Health News:UV Technologies Bold Prediction on H7N9 in China Comes True, New Cases End Without Aid of Flu Vaccine 3Health News:EnvirOasis Lighting Announces Energy Star and Design Lights Consortium LED Products 2Health News:U.S. Teen Birth Rate Plummets: Report 2Health News:U.S. Teen Birth Rate Plummets: Report 3
... David Spiegel of Faculty of 1000 Medicine ( www.f1000medicine.com ... and survival rates in older patients. He identifies it ... of treatment of depression on survival in a primary ... and professor of psychiatry and behavioural sciences at Stanford ...
... Program Focused on ... for Healthcare Workers From ... April 11 - 14, PARSIPPANY, N.J., ... in the days,before the tax filing deadline are likely to leave with a ...
... Expand ... Network, STAMFORD, Conn., ... on lower middle-market special situation,and deep value investments, announced today that it ... Street,Capital with a commitment from funds managed by the investment management,arm of ...
... The HealthCentral,Network, Inc. (http://www.healthcentral.com ) announced ... information resource for people living with ADHD ... highly targeted and quality,healthcare sites., The ... ad representation.,ADDitudemag.com will work with HealthCentral,s ADHDCentral.com, ...
... Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center ... for their internationally recognized contributions to medicine at its ... National Golf Club. , Dominic DeCristofaro, M.D., Grant B. ... Legends to be honored at the dinner event. All ...
... April 10 "Often we try to emulate,others, ... someone,s new,exercise program -- resulting in frustration and ... because they are not your own idea of ... --, http://www.authorhouse.com ), the latest offering in his ...
Cached Medicine News:Health News:Jackson Hewitt(R) Celebrates Healthcare Workers With Occupation-Based Tax Savings 2Health News:Jackson Hewitt(R) Celebrates Healthcare Workers With Occupation-Based Tax Savings 3Health News:Atlantic Street Capital Announces First Close 2Health News:The HealthCentral Network Adds New Hope Media's ADDitudemag.com to its Premier Network of High Quality Sites 2Health News:The HealthCentral Network Adds New Hope Media's ADDitudemag.com to its Premier Network of High Quality Sites 3Health News:LA BioMed to honor 3 of its legendary 2Health News:LA BioMed to honor 3 of its legendary 3Health News:LA BioMed to honor 3 of its legendary 4Health News:LA BioMed to honor 3 of its legendary 5Health News:'Champion Health': Learn How to Create a Unique, Personalized Health Plan That Works and Keeps Working 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: